Zdrowie i gospodarka · 6.08.1998
Biotechnology Manufacturing Grassroots Meeting
The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Pacific Region, and the Center for Biologics Evaluation and Research (CBER), is announcing the following meeting: Biotechnology Manufacturing Grassroots Meeting. The topic to be discussed is mechanisms and processes through which the agency could potentially increase operational efficiency in relation to both the pre- and post- approval inspection process; improve communication and cooperation among CBER, FDA field offices, and industry representatives associated with biotechnology manufacturing processes; and improve levels of consumer protection.